Business
BNCM: DELEX PHARMA Bolsters Market Reach Through 6 Major Conventions in November 2024
BNCM: DELEX PHARMA Bolsters Market Reach Through 6 Major Conventions in November 2024.
About this update from Bounce Mobile Systems, Inc.
[{"type":"text","content":"Delex Pharma International, Inc. (Delex Pharma) strengthened its market presence in 2024 by complementing its digital initiatives, such as the ICU Forum, with participation in six major on-ground conventions, the majority of which took place in November 2024. Additionally, we have conducted hybrid webinars and events with forty-four (44) partner medical societies and hospital departments. These events target key healthcare professionals across multiple specialties, enhancing brand visibility and engagement. Penetrating the Anesthesia MarketDelex Pharma’s Anesthesia business unit achieved 37% growth this year and further solidified its market reach at the 2024 Annual Convention and Postgraduate Course Scientific Program, held from November 27 to 29, 2024, at the Marriott Grand Ballroom in Pasay City. Engaging nearly 3,000 anesthesiologists, Delex Pharma showcased its broadened anesthesia portfolio, including intravenous solutions like Ibuprofen (Intrafen), Paracetamol (Ifimol), Propofol (Delexofol), and Dexmedetomidine Hydrochloride (Predex). Meanwhile, Ibuprofen (Intrafen) is an innovator brand and the first and only IV Ibuprofen in the Philippines, launched in August 2018, with significant sales opportunities anticipated.The company also highlighted new offerings such as Etoricoxib (Exib 120 and 90), which is an oral medicine, and Fentanyl (Fentalex), a transdermal patch, addressing the growing demand for anesthesia innovations in the Philippines. Similarly, Verathon’s GlideScope, a video-assisted laryngoscopy tool, was also highlighted. This invaluable device continues to see growing demand for airway management among anesthesiologists in various clinical settings.Link to Video: https://delexhealth.com/delex-psa-annual-convention-2024/ Cultivating Bonds with Hospital Decision-MakersTo magnify our pharmaceutical and medical device businesses, we actively promoted our diverse product portfolio—ranging from critical care, anesthesia, anti-infectives, oncology, medical devices, and women’s health—during the Philippine Hospital Administrators (PHA) Convention held at the Manila Hotel from November 20 to 22, 2024. Our team engaged with nearly 2,000 decision-makers and top executives, including chief executive officers (CEOs), hospital administrators, medical directors, chief nursing officers (CNOs), finance managers, and p...